Oncostatin m impairs brown adipose tissue thermogenic function and the browning of subcutaneous white adipose tissue. 2017

David Sánchez-Infantes, and Rubén Cereijo, and Marion Peyrou, and Irene Piquer-Garcia, and Jacqueline M Stephens, and Francesc Villarroya
Department of Endocrinology and Nutrition, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Barcelona, Spain.

Since oncostatin m (OSM) is elevated in adipose tissue in conditions of obesity and type 2 diabetes in mice and humans, the aim of this study was to determine whether this cytokine plays a crucial role in the impairment of brown adipose tissue (BAT) activity and browning capacity that has been observed in people with obesity. C57BL/6J mice rendered obese by high-fat diet, their lean controls, and C57BL/6J mice fed a standard diet and implanted subcutaneously with a mini pump through a surgical procedure to deliver OSM or placebo were used. Preadipocytes or fully differentiated brown adipocytes were treated with OSM or vehicle with or without norepinephrine before harvesting. RNA was extracted and processed for qPCR analysis. Media from mature adipocytes was also collected to measure glycerol levels. Studies demonstrated that OSM gene expression was increased in BAT of mice fed a high-fat diet. In addition, exogenous OSM impaired BAT activity and the browning capacity of white adipose tissue in vitro and in vivo. Overall, the results reveal a negative role for OSM on BAT and on the browning of white adipose tissue. Therefore, further studies are necessary to demonstrate whether OSM inhibition is a potential treatment for metabolic disorders.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002001 Adipose Tissue, Brown A thermogenic form of adipose tissue composed of BROWN ADIPOCYTES. It is found in newborns of many species including humans, and in hibernating mammals. Brown fat is richly vascularized, innervated, and densely packed with MITOCHONDRIA which can generate heat directly from the stored lipids. Brown Fat,Hibernating Gland,Brown Adipose Tissue,Fat, Brown,Tissue, Brown Adipose
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D050151 Subcutaneous Fat Fatty tissue under the SKIN through out the body. Adipose Tissue, Subcutaneous,Fat, Subcutaneous,Subcutaneous Adipose Tissue,Fats, Subcutaneous,Subcutaneous Fats
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D052436 Adipose Tissue, White Fatty tissue composed of WHITE ADIPOCYTES and generally found directly under the skin (SUBCUTANEOUS FAT) and around the internal organs (ABDOMINAL FAT). It has less vascularization and less coloration than the BROWN FAT. White fat provides heat insulation, mechanical cushion, and source of energy. White Fat,White Adipose Tissue,Fat, White,Tissue, White Adipose
D052437 Adipocytes, Brown Fat cells with dark coloration due to the densely packed MITOCHONDRIA. They contain numerous small lipid droplets or vacuoles. Their stored lipids can be converted directly to energy as heat by the mitochondria. Brown Adipocytes,Brown Fat Cells,Adipocyte, Brown,Brown Adipocyte,Brown Fat Cell,Cell, Brown Fat,Cells, Brown Fat,Fat Cell, Brown,Fat Cells, Brown
D053683 Oncostatin M A cytokine with both pro- and anti-inflammatory actions that depend upon the cellular microenvironment. Oncostatin M is a 28 kDa monomeric glycoprotein that is similar in structure to LEUKEMIA INHIBITORY FACTOR. Its name derives from the the observation that it inhibited the growth of tumor cells and augmented the growth of normal fibroblasts.

Related Publications

David Sánchez-Infantes, and Rubén Cereijo, and Marion Peyrou, and Irene Piquer-Garcia, and Jacqueline M Stephens, and Francesc Villarroya
March 2019, Cell reports,
David Sánchez-Infantes, and Rubén Cereijo, and Marion Peyrou, and Irene Piquer-Garcia, and Jacqueline M Stephens, and Francesc Villarroya
July 2019, Diabetes,
David Sánchez-Infantes, and Rubén Cereijo, and Marion Peyrou, and Irene Piquer-Garcia, and Jacqueline M Stephens, and Francesc Villarroya
February 2019, Molecular and cellular endocrinology,
David Sánchez-Infantes, and Rubén Cereijo, and Marion Peyrou, and Irene Piquer-Garcia, and Jacqueline M Stephens, and Francesc Villarroya
May 2020, Journal of physiology and biochemistry,
David Sánchez-Infantes, and Rubén Cereijo, and Marion Peyrou, and Irene Piquer-Garcia, and Jacqueline M Stephens, and Francesc Villarroya
July 2022, International journal of molecular sciences,
David Sánchez-Infantes, and Rubén Cereijo, and Marion Peyrou, and Irene Piquer-Garcia, and Jacqueline M Stephens, and Francesc Villarroya
August 2016, Best practice & research. Clinical endocrinology & metabolism,
David Sánchez-Infantes, and Rubén Cereijo, and Marion Peyrou, and Irene Piquer-Garcia, and Jacqueline M Stephens, and Francesc Villarroya
November 2019, Molecular metabolism,
David Sánchez-Infantes, and Rubén Cereijo, and Marion Peyrou, and Irene Piquer-Garcia, and Jacqueline M Stephens, and Francesc Villarroya
December 2023, EMBO reports,
David Sánchez-Infantes, and Rubén Cereijo, and Marion Peyrou, and Irene Piquer-Garcia, and Jacqueline M Stephens, and Francesc Villarroya
March 2016, Journal of lipid research,
David Sánchez-Infantes, and Rubén Cereijo, and Marion Peyrou, and Irene Piquer-Garcia, and Jacqueline M Stephens, and Francesc Villarroya
June 2017, The EMBO journal,
Copied contents to your clipboard!